Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Operating Expenses Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Operating Expenses
-â‚ą16.8B
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
-16%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Expenses
-â‚ą140B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Expenses
-â‚ą121.4B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Expenses
-â‚ą285.7B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Expenses
-â‚ą56.9B
CAGR 3-Years
-12%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Expenses
-â‚ą47.9B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Operating Expenses?
Operating Expenses
-16.8B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Operating Expenses amounts to -16.8B INR.

What is Natco Pharma Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-16%

Over the last year, the Operating Expenses growth was -21%. The average annual Operating Expenses growth rates for Natco Pharma Ltd have been -16% over the past three years , -10% over the past five years , and -16% over the past ten years .

Back to Top